Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Sept 2026 for Alphabet Inc., €25k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Arnold Frances: trading record in brief
This profile gathers the share dealings of Arnold Frances across 2 companies, led by Alphabet Inc. and Generate Biomedicines, Inc. In total, 5 filings cover trades dated from 30 June 2026 to 30 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 30 September 2026 came the latest disclosure, a transaction for €25k in Alphabet Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arnold Frances
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
83 shares@ US$340.4458Class C Capital StockSEC144:0001921094-26-001058
1,000 shares@ US$16.002100.0% of flowCommonSEC144:0001959173-26-006611
82 shares@ US$337.70730.0000% mcap1.8% of flowClass C Capital StockSEC144:0001921094-26-000964
82 shares@ US$333.39020.0000% mcap1.8% of flowClass C Capital StockSEC144:0001921094-26-000772
112 shares@ US$351.27680.0000% mcap2.6% of flowClass C Capital StockSEC144:0001921094-26-000693
5 of 5 declarations
